PLASMA SELF-SUFFICIENCY AND DONOR PLASMAPHERESIS IN JAPAN

Self Sufficiency In Plasma And Plasma Derived Medicines

self sufficiency in plasma and plasma derived medicines

0

The Iranian Blood Transfusion, Donor Safety Program: Effect of Long-term Plasmapheresis on Plasma Proteins

Background: Plasmapheresis is a well-recognised method for harvestingplasma.  It was introduced in the 1950s and is currently employed worldwide.  This method has been in use in Iran since 1979. Objective: To evaluate the efficacy of donor safety program used at the Iranian Blood Transfusion Organization. Methods: A comparison is made of the protein concentrations between the first-time and lon...

Donor Hemovigilance during Preparatory Plasmapheresis.

BACKGROUND Reports on unexpected donor events (UEs) during preparatory plasmapheresis (PPP) are scarce, and rarely consider technical UEs. METHODS Defined local and systemic UEs were graded by severity; technical UEs were not graded. On January 1, 2008, E.B.P.S.-Logistics (EBPS) installed the UE module for plasma management software (PMS). Donor room physicians entered UEs daily into the PMS....

Plasma fractionation in Korea: working towards self-sufficiency

OVERVIEW The plasma supply for pharmaceutical manufacturing consists of surplus plasma recovered from whole blood collection and source plasma from plasmapheresis in Korea. Shortages are typically covered by importation. The total plasma supply for fractionation was 608,352 liters in 2009, of which 430,267 liters were supplied domestically. The self-sufficiency rate was, therefore, about 71% in...